Analysis of UNOS: Ventricular Assist Device as Bridge-to-Transplant in Paediatric Patients With Congenital Heart Disease
European Journal of Cardio-Thoracic Surgery · 2025
DOI: 10.1093/ejcts/ezaf290 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2025. Verfasst von Ahmet Bilgili und 5 weiteren Autor:innen. Beteiligte Einrichtung: Congenital Heart Center, University of Florida, Gainesville, FL 32608, United States. Hauptthemen laut MEDLINE: Heart-Assist Devices, Heart Transplantation, Heart Defects, Congenital, Waiting Lists. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
Background
In a multi-institutional contemporary cohort of patients < 18 years with congenital heart disease (CHD), we compare outcomes of bridge-to-transplant with and without ventricular assist device (VAD).
Methods
The United Network for Organ Sharing was queried for all patients <18 years with CHD listed for cardiac transplantation (January 1, 2014, to December 31, 2023). Patients were split into 2 cohorts based on the presence of VAD while on the waitlist. Univariable and multivariable analyses were performed to assess baseline characteristics and post-transplant survival.
Results
The overall patient cohort consisted of 3394 CHD patients listed for cardiac transplantation at 65 centres: 561/3394 = 16.5% had VAD support while on the waitlist and 2833/3394 = 83.5% did not. A total of 396/561 = 70.6% of VAD-supported patients and 1852/2833 = 65.4% of non-VAD–supported patients underwent cardiac transplantation. Waitlist mortality, defined as death or removal from waitlist due to clinical deterioration, was 602/3394 = 17.7% for all patients, 144/561 = 25.7% for VAD-supported patients, and 458/2833 = 16.2% for non-VAD–supported patients. Among the 2248 transplanted CHD patients transplanted at 65 centres (n = 396 VAD-supported, n = 1852 non-VAD–supported), Berlin Heart was the most frequently used VAD (209/396 = 52.8%), and VAD configuration was mostly left ventricular assist device (306/396 = 77.3%). VAD support among CHD patients < 18 bridged-to-transplant increased (20 in 2014, 73 in 2023). VAD-supported patients had similar rates of post-transplant stroke (25/389 = 6.4% vs 83/1835 = 4.5%, P = .145) and episodes of acute rejection (60/396 = 15.2% vs 305/1852 = 16.5%, P = .582) compared to non-VAD–supported patients. No significant differences between VAD-supported and non-VAD–supported patients were seen in longitudinal post-transplant survival up to 5 years (log-rank P = .257).
Conclusions
In the last decade, patients <18 years with CHD bridged-to transplant with VAD achieve post-transplant outcomes and long-term survival similar to those bridged without VAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Congenital Heart Center, University of Florida, Gainesville, FL 32608, United States.
ORCID-Profile: Ahmet Bilgili, Jeffrey Phillip Jacobs
Zitieren
APA
Bilgili, A., Pendarvis, J., Sharaf, O. M., Peek, G. J., Bleiweis, M. S., & Jacobs, J. P. (2025). Analysis of UNOS: Ventricular Assist Device as Bridge-to-Transplant in Paediatric Patients With Congenital Heart Disease. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezaf290
Vancouver
Bilgili A, Pendarvis J, Sharaf OM, Peek GJ, Bleiweis MS, Jacobs JP. Analysis of UNOS: Ventricular Assist Device as Bridge-to-Transplant in Paediatric Patients With Congenital Heart Disease. European Journal of Cardio-Thoracic Surgery. 2025. doi:10.1093/ejcts/ezaf290
BibTeX
@article{Bilgili2025,
author = {Bilgili, Ahmet and Pendarvis, Jordyn and Sharaf, Omar M and Peek, Giles J and Bleiweis, Mark Steven and Jacobs, Jeffrey Phillip},
title = {Analysis of UNOS: Ventricular Assist Device as Bridge-to-Transplant in Paediatric Patients With Congenital Heart Disease},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2025},
doi = {10.1093/ejcts/ezaf290}
}
EUVIMED